Cleo Diagnostics patents ovarian cancer test IP; shares jump on low liquidity

As reported by themarketherald.com.au

Ovarian cancer detection biotech Cleo Diagnostics (ASX: COV) has seen shares jump towards +4% on Wednesday as it patents its ovarian cancer screening test – o...

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on themarketherald.com.au ↗

Market Samachar is a news aggregator. This article was originally published by themarketherald.com.au. Tap the button above to read the full story on their site.

INDIAN Inox Clean Energy files DRHP for Rs 10,000 crore IPO. Check details Markets-Economic Times
INDIAN Stock Market LIVE: Sensex, Nifty stuck in range; Coforge, OFSS lead MidCap gains Share Market Today
INDIAN Solar Industries shares up over 6%! What's driving defence stock that has surged 60% in YTD | Check target price mint - markets
INDIAN Tega Industries shares jump 6% | What’s driving the stock’s 30% monthly rally? mint - markets
CRYPTO XRP Ledger starts carrying fund records from Brazil operator overseeing $4 trillion CoinDesk: Bitcoin, Ethereum, Crypto News and Price Data
GLOBAL Drop in donations puts community pantry at risk BBC News
COMPANIES Cupid, Sterlite Tech among 10 smallcap stocks set for sharp fund flows after Nifty rejig. See full list Stocks-Markets-Economic Times
INDIAN Parag Thakkar Bets On HDFC Bank At Rs 925, Sees Nearly 30% Upside NDTV Profit - Latest

Cleo Diagnostics patents ovarian cancer test IP; shares jump on low liquidity

More from Market Samachar